Delivery Order SPE2DB25D3017-SPE2DB25FVKAY
- Not listed
- The Defense Logistics Agency awarded a $1,501.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens (0.5 mL units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitive award, which was issued without a set-aside designation, is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,756.58 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price contract is a non-set-aside competitive award and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens valued at $1,417.72 on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency awarded a delivery order valued at $1,042.42 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA for pharmaceutical...
- The Defense Logistics Agency awarded a $3,415.89 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on July 25, 2025, with a completion date of July 28, 2025. This firm fixed-price contract, which was not set-aside, represents a small delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, the company's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $1,089.15 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injections on July 25, 2025, with completion scheduled for July 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections in 0.5 ml doses, valued at $10,714.36. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a $6,038.30 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded contract, issued without set-aside designation, represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the company's headquarters location in...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKAYDelivery Order
The Defense Logistics Agency awarded a $3,731.10 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen (0.5ml) on July 30, 2025, with a completion date of July 31, 2025. This firm fixed-price contract, which carries no set-aside designation, was competitively awarded and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle. The pharmaceutical will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Trulicity order supports the Defense Health Agency and other government healthcare systems through this flexible contract mechanism, which encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 7/30/25 |